In cutaneous T-cell lymphomas, an additional layer of complexity is provided by the fact that malignant T cells themselves may express PD-1, and thus blockade of the PD-1/PD-L1 axis could potentially activate the malignant cells. The gene discussed is CD274; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.